Nearly half of medtech executives polled in a recent survey said their companies are prepared for the second wave of the COVID-19 pandemic that is sweeping the globe.
Forty-eight percent of the 71 MedExecWomen Fall Forum attendees who responded to the question reported their companies’ readiness hinged on scalable remote commercial capabilities, a bolstered supply chain and pandemic response protocols.
Forty-one percent said they are starting to implement measures learned from the first wave, including getting traction on remote capabilities, starting on supply chain mitigation plans and putting preliminary response systems in place. Only 11% reported that their company hasn’t made significant changes in the way they’re working. These latter executives said their firms have limited scalable remote commercial capabilities and have made minor supply chain changes.